Last deal
Amount
Stage
Date
all rounds
Total amount
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Abata Therapeutics
Abata Therapeutics develops cell therapy to treat autoimmune and inflammatory diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Skyhawk Therapeutics
Skyhawk Therapeutics develops small molecule therapeutics to correct RNA expression.
Sector
Subsector
Location
total rounds
total raised
Sonoma BioTherapeutics
Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.
Sector
Subsector
Location
total rounds
total raised
Clade Therapeutics
Clade Therapeutics is a biopharmaceutical company that develops next-generation stem-cell-based medicines.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds1
Number of Funding Rounds
Money Raised
Their latest funding was raised on 21.09.2023. Their latest investor John Ballantyne. Their latest round Seed
Co-Investors
Investors6
Number of lead investors
Number of investors
John Ballantyne
count Of Investments
Michael Chambers
count Of Investments
Josh Ellington
count Of Investments
People
Founders2
Julie Norville
Julie Norville is the current Founder , CSO and CTO of JURA Bio. She previously worked at Harvard Medical School as a Research Fellow in Genetics in the Laboratory of George Church. Julie Norville attended Massachusetts Institute of Technology.
current job
organization founded
Julie Norville
George Church
George Church is a leading expert in human genetics and biotechnology.He has served as professor of genetics at Harvard Medical School since 1986 and currently serves as professor of health sciences and technology at Harvard and the Massachusetts Institute of Technology (MIT).He is also director of the U.S. Department of Energy Center on Bioenergy at Harvard and MIT and director of the National Institutes of Health Center of Excellence in Genomic Science at Harvard. Church helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005. Church pioneered genome engineering, systems and synthetic biology, and concepts of molecular multiplexing and tags, and he has a successful track record of developing and transferring new technologies to more than 20 companies. Church has received numerous awards, including the 2011 Bower Award and Prize for Achievement in Science from the Franklin Institute, the 2009 Promega Biotechnology Research Award from the American Society for Microbiology, and was honored in The Scientist’s Top 10 Innovations list in 2008. Church holds a Ph.D. in biochemistry and molecular biology from Harvard University and a B.A. in zoology and chemistry from Duke University.
current job
organization founded
George Church